Mitogen-activated protein kinase: Difference between revisions
New page: left|thumb|300px|Crystal Structure of the Mitogen-activated protein kinase, [[1erk]] {{STRUCTURE_1erk| right| PDB=1erk | SCENE= |CAPTION=Mitogen-activated protein kina... |
Michal Harel (talk | contribs) No edit summary |
||
(39 intermediate revisions by 3 users not shown) | |||
Line 1: | Line 1: | ||
[[ | <StructureSection load='' size='350' side='right' caption='Human MAPK1 complex with inhibitor and sulfate (PDB entry [[2ojg]])' scene='43/438476/Cv/2'> | ||
== Function == | |||
[[Mitogen-activated protein kinase]] (MAPK) also known as '''Extracellular Signal-Regulated Kinase (ERK)''' are serine/threonine kinases which regulate various cellular activities in response to extracellular stimuli by mitogens, heat shock and more. MAPK is part of the MAPK cascade which consists of MAPK, [[Mitogen-activated protein kinase kinase|MAP2K]] and [[Mitogen-activated protein kinase kinase kinase|MAP3K]] which are activated by phosphorylation<ref>PMID:9069255</ref>. <br /> | |||
[[Mitogen-activated protein kinase | See also [[Mitogen-activated protein kinase cascade]]. | ||
* '''MAPK1''' or '''ERK2''' and '''MAPK3''' are activated in response to growth factors. For '''MAPK1''' representations see [[Michael Roberts/BIOL115/ERK2]].<br /> | |||
<br /> | * '''MAPK6''' is activated by phorbol esters.<br /> | ||
<br /> | * '''MAPK7''' is activated by stress stimuli.<br /> | ||
<br /> | * '''MAPK8 (called also c-Jun N-terminal kinase 1 or JNK1), MAPK9, MAPK10''' (called also c-Jun N-terminal kinase 3 or JNK3), '''MAPK11, MAPK12, MAPK13, MAPK14''' are stress-activated.<br /> | ||
<br /> | * '''MAPK11''' (also called '''p38-β MAPK'''), '''MAPK12''' (also called '''p38-γ MAPK'''), '''MAPK13''' (also called '''p38-δ MAPK'''), '''MAPK14''' (also called '''p38-α MAPK''') belongs to the class called [[UMass Chem 423 Student Projects 2011-2#p38 kinase|p38 MAPK (UMass Chem 423 Student Projects 2011-2)]]. | ||
== | == Relevance == | ||
MAPK cascade is elevated in cancer cells, hence MAPK inhibitors are tested as potential cancer therapy. | |||
=== | == Disease == | ||
MAPK14 is associated with acquired hyperkeratosis and prostate transitional cell carcinoma. | |||
== | == Structural highlights == | ||
<scene name='43/438476/Cv/5'>Inhibitors of MAPK bind in its ATP-binding site</scene><ref>PMID:17300186</ref>. Water molecule are shown as red sphere. | |||
== 3D Structures of Mitogen-activated protein kinase == | |||
[[Mitogen-activated protein kinase 3D structures]] | |||
== | |||
[[ | |||
</StructureSection> | |||
== References == | |||
<references/> | |||
[[Category:Topic Page]] | [[Category:Topic Page]] |
Latest revision as of 11:23, 20 January 2022
FunctionMitogen-activated protein kinase (MAPK) also known as Extracellular Signal-Regulated Kinase (ERK) are serine/threonine kinases which regulate various cellular activities in response to extracellular stimuli by mitogens, heat shock and more. MAPK is part of the MAPK cascade which consists of MAPK, MAP2K and MAP3K which are activated by phosphorylation[1]. See also Mitogen-activated protein kinase cascade.
RelevanceMAPK cascade is elevated in cancer cells, hence MAPK inhibitors are tested as potential cancer therapy. DiseaseMAPK14 is associated with acquired hyperkeratosis and prostate transitional cell carcinoma. Structural highlights[2]. Water molecule are shown as red sphere. 3D Structures of Mitogen-activated protein kinaseMitogen-activated protein kinase 3D structures
|
|
ReferencesReferences
- ↑ Robinson MJ, Cobb MH. Mitogen-activated protein kinase pathways. Curr Opin Cell Biol. 1997 Apr;9(2):180-6. PMID:9069255
- ↑ Aronov AM, Baker C, Bemis GW, Cao J, Chen G, Ford PJ, Germann UA, Green J, Hale MR, Jacobs M, Janetka JW, Maltais F, Martinez-Botella G, Namchuk MN, Straub J, Tang Q, Xie X. Flipped out: structure-guided design of selective pyrazolylpyrrole ERK inhibitors. J Med Chem. 2007 Mar 22;50(6):1280-7. Epub 2007 Feb 15. PMID:17300186 doi:http://dx.doi.org/10.1021/jm061381f